Home
HelpTest ID FBRIV Brivaracetam, Plasma
Specimen Required
***Must submit one specimen per order. Specimens cannot be shared between multiple orders.***
Specimen Type: Plasma
Collection Container/Tube: Lavender top or pink top (EDTA)
Submission Container/Tube: Plastic vial
Specimen Volume: 1 mL
Collection Instructions:
1. Draw blood in an EDTA (lavender top or pink top) tube(s). Plasma gel tube is not acceptable.
2. Centrifuge and send 1 mL of plasma refrigerated in a preservative-free plastic vial.
Secondary ID
75682Method Name
High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS)
Reporting Name
Brivaracetam, PlasmaSpecimen Type
Plasma EDTASpecimen Minimum Volume
0.2 mL
Specimen Stability Information
| Specimen Type | Temperature | Time |
|---|---|---|
| Plasma EDTA | Refrigerated (preferred) | 30 days |
| Frozen | 120 days | |
| Ambient | 30 days |
Clinical Information
The recommended steady-state brivaracetam plasma concentration for seizure control is 0.2 to 2.0 mcg/mL.
Reference Values
Reporting limit determined each analysis
Units: mcg/mL
Day(s) Performed
Monday through Sunday
Report Available
10 to 12 daysPerforming Laboratory
NMS LabsTest Classification
This test was developed and its performance characteristics determined by NMS Labs. It has not been cleared or approved by the U.S. Food and Drug Administration.CPT Code Information
80299